Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Agency Summary Page

Agency Name: Multistate Attorneys General Case
Penalty Total since 2000: $166,517,658,344
Number of Records: 754
Note: The penalty total above and the parent totals below include some cases in which both a state and a federal agency were involved and issued separate announcements of the outcome. The individual penalty records below marked by an asterisk are ones for which Violation Tracker contains a separate federal entry.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Bank of America$26,114,848,40810
UBS$11,593,380,0006
Citigroup$8,235,591,5777
McKesson$8,152,000,0002
AmerisourceBergen$6,623,275,0003
Cardinal Health$6,489,000,0001
JPMorgan Chase$6,238,338,66111
Johnson & Johnson$6,079,941,5169
Walgreens Boots Alliance$5,800,210,0007
CVS Health$5,215,960,16615

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentCurrent Parent Industry sort iconPrimary Offense TypeYearPenalty Amount
Apria Healthcare Group, Inc. and Apria Healthcare LLCBlackstoneprivate equity (including portfolio companies)False Claims Act and related2021(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000
PharMerica Inc.KKR & Co.private equity (including portfolio companies)kickbacks and bribery2022$4,900,000
El Paso CorporationKinder Morganpipelinesprice-fixing or anti-competitive practices2003$1,450,000,000
SunocoEnergy Transferpipelinesenvironmental violation2005(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,900,000
Abbott LaboratoriesAbbott LaboratoriespharmaceuticalsFalse Claims Act and related2003(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $32,500,000
Abbott LaboratoriesAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2012(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Abbott LaboratoriesAbbViepharmaceuticalsprice-fixing or anti-competitive practices2005$15,350,000
Abbott LaboratoriesAbbViepharmaceuticalsprice-fixing or anti-competitive practices2010$22,500,000
AbbVie Inc.AbbViepharmaceuticalskickbacks and bribery2018(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,800,000
Aegerion Pharmaceuticals Inc.Amryt PharmapharmaceuticalsFalse Claims Act and related2017(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000
Alere Inc.Abbott LaboratoriespharmaceuticalsFalse Claims Act and related2018(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,860,779
Allergan Inc.AbbViepharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000
Alpharma Inc.PfizerpharmaceuticalsFalse Claims Act and related2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000
Alpharma, Inc.Pfizerpharmaceuticalsprice-fixing or anti-competitive practices2004$750,000
Amgen Inc.Amgenpharmaceuticalsoff-label or unapproved promotion of medical products2012(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000
Amgen Inc.Amgenpharmaceuticalsoff-label or unapproved promotion of medical products2015$71,000,000
Amgen, Inc.AmgenpharmaceuticalsFalse Claims Act and related2013$11,000,000
Andrx CorporationTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2003$40,000,000
Astellas Pharma US Inc.Astellas PharmapharmaceuticalsFalse Claims Act and related2014(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,100,000
AstraZeneca LPAstraZenecapharmaceuticalsFalse Claims Act and related2015(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000
AstraZeneca PharmaceuticalsAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2011$68,500,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsFalse Claims Act and related2003(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsFalse Claims Act and related2009(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Aventis Pharmaceutical Inc.SanofipharmaceuticalsFalse Claims Act and related2009(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000
Aventis Pharmaceuticals Inc.SanofipharmaceuticalsFalse Claims Act and related2007(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600
Aventis Pharmaceuticals Inc.Sanofipharmaceuticalsprice-fixing or anti-competitive practices2003$40,000,000
Aventis Pharmaceuticals, Inc.Sanofipharmaceuticalsprice-fixing or anti-competitive practices2012$1,650,000
Barr PharmaceuticalsTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2008$5,900,000
Bausch & LombBausch Healthpharmaceuticalsprice-fixing or anti-competitive practices2001$17,500,000
Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimpharmaceuticalsoff-label or unapproved promotion of medical products2017$13,500,000
Boehringer-Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimpharmaceuticalsoff-label or unapproved promotion of medical products2012(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000
Bristol-Myers SquibbBristol-Myers SquibbpharmaceuticalsFalse Claims Act and related2008(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000
Bristol-Myers SquibbBristol-Myers Squibbpharmaceuticalsoff-label or unapproved promotion of medical products2016$19,500,000
Bristol-Myers SquibbBristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2003$55,000,000
Bristol-Myers Squibb Co.Bristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2003$100,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2008$1,100,000
Celgene Corp.Bristol-Myers Squibbpharmaceuticalsoff-label or unapproved promotion of medical products2017(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000
CephalonTeva Pharmaceutical Industriespharmaceuticalsconsumer protection violation2016$125,000,000
Cephalon Inc.Teva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2008(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
Cephalon, Inc.Teva Pharmaceutical IndustriespharmaceuticalsFalse Claims Act and related2015(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000
CIBA VisionNovartispharmaceuticalsprice-fixing or anti-competitive practices2000$5,000,000
Daiichi PharmaceuticalDaiichi Sankyopharmaceuticalsprice-fixing or anti-competitive practices2000$4,340,100
Daiichi Sankyo, Inc.Daiichi SankyopharmaceuticalsFalse Claims Act and related2015$39,000,000
Dava Pharmaceuticals, Inc.Endo InternationalpharmaceuticalsFalse Claims Act and related2012(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000
EisaiEisaipharmaceuticalsprice-fixing or anti-competitive practices2000$7,634,700
Eisai Inc.Eisaipharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249
Elan Corp.Perrigopharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040
Eli Lilly & Co.Eli Lillypharmaceuticalsprivacy violation2002$160,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2008$62,000,000
EMD Serono, Inc.Merck KGaA (EMD)pharmaceuticalsFalse Claims Act and related2011(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $44,300,000
Endo Health SolutionEndo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2014(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
Endo Health SolutionsEndo InternationalpharmaceuticalsFalse Claims Act and related2015(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000
Endo International plcEndo Internationalpharmaceuticalsprice-fixing or anti-competitive practices2019$2,300,000
Forest Laboratories LLCAbbViepharmaceuticalsFalse Claims Act and related2016(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,500,000
Forest Pharmaceuticals Inc.AbbViepharmaceuticalsFalse Claims Act and related2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000
Genentech Inc.RochepharmaceuticalsFalse Claims Act and related2016(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000
Genentech Inc.Rochepharmaceuticalsoff-label or unapproved promotion of medical products2000$19,000,000
Geneva PharmaceuticalsNovartispharmaceuticalsprice-fixing or anti-competitive practices2005$15,350,000
Genzyme Corp.SanofipharmaceuticalsFalse Claims Act and related2013(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsFalse Claims Act and related2003$40,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsFalse Claims Act and related2005(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsoff-label or unapproved promotion of medical products2012(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
GlaxoSmithKline LLCGlaxoSmithKlinepharmaceuticalsdrug or medical equipment safety violation2012$90,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2006$70,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2006$14,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2006$3,500,000
GlaxoSmithKline, LLCGlaxoSmithKlinepharmaceuticalsdrug or medical equipment safety violation2011$40,750,000
GlaxoSmithKline, LLCGlaxoSmithKlinepharmaceuticalskickbacks and bribery2014$105,000,000
Hoffman-LaRocheRochepharmaceuticalsprice-fixing or anti-competitive practices2000$142,494,000
Inspire PharmaceuticalsMerckpharmaceuticalsoff-label or unapproved promotion of medical products2015(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000
InterMune Inc.Rochepharmaceuticalsoff-label or unapproved promotion of medical products2006(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000
ISTA Pharmaceuticals, Inc.Bausch Healthpharmaceuticalsoff-label or unapproved promotion of medical products2013(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253
IVAX PharmaceuticalsTeva Pharmaceutical IndustriespharmaceuticalsFalse Claims Act and related2009(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2012$181,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsdrug or medical equipment safety violation2019$120,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsdrug or medical equipment safety violation2017$33,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2013(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000
Johnson & Johnson Vision Care, Inc.Johnson & Johnsonpharmaceuticalsprice-fixing or anti-competitive practices2001$60,000,000
King PharmaceuticalsPfizerpharmaceuticalsFalse Claims Act and related2006(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000
Kos PharmaceuticalsAbbViepharmaceuticalskickbacks and bribery2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432
Mallinckrodt LLCMallinckrodtpharmaceuticalsFalse Claims Act and related2013(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000
Mallinckrodt plcMallinckrodtpharmaceuticalsprice-fixing or anti-competitive practices2017(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000
Medicis Pharmaceutical CorporationBausch Healthpharmaceuticalsoff-label or unapproved promotion of medical products2007(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000
MerckMerckpharmaceuticalsFalse Claims Act and related2008(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000
Merck & Co. Inc.Merckpharmaceuticalsconsumer protection violation2009$5,400,000
Merck & Co.Merckpharmaceuticalsconsumer protection violation2008$58,000,000
Merck KGaAMerck KGaA (EMD)pharmaceuticalsprice-fixing or anti-competitive practices2009$2,275,454
Merck Sharp & Dohme Corp.Merckpharmaceuticalsoff-label or unapproved promotion of medical products2012(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000
Mylan Inc.ViatrispharmaceuticalsFalse Claims Act and related2017(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000
Mylan Laboratories et al.Viatrispharmaceuticalsprice-fixing or anti-competitive practices2000(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000
Mylan Pharmaceuticals, Inc.ViatrispharmaceuticalsFalse Claims Act and related2009(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000
Novartis Pharmaceuticals CorporationNovartispharmaceuticalskickbacks and bribery2015(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754
Novartis Pharmaceuticals CorporationNovartispharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartispharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
Novo Nordisk Inc.Novo Holdings A/SpharmaceuticalsFalse Claims Act and related2017(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963
Novo Nordisk Inc.Novo Holdings A/Spharmaceuticalsoff-label or unapproved promotion of medical products2011(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209
OrganonOrganon & Co.pharmaceuticalsoff-label or unapproved promotion of medical products2014$31,000,000
Organon USA IncOrganon & Co.pharmaceuticalsprice-fixing or anti-competitive practices2004$36,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2010(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.